Health CVS Health Restores Zepbound Coverage After Landmark Pricing Deal May 28, 2026 Major Shift in Weight-Loss Drug Coverage CVS Health announced Thursday it will restore coverage for Eli Lilly’s weight-loss drug Zepbound on select formularies. The pharmacy giant will add the treatment…
Health Lilly’s Retatrutide Shows Dramatic Weight Loss in Phase 3 Obesity Trial May 21, 2026 Groundbreaking Phase 3 Results for Triple Agonist Therapy Eli Lilly announced positive topline results from TRIUMPH-1, a pivotal Phase 3 clinical trial. The study evaluated retatrutide, an investigational triple hormone…
Health Daily Weight Loss Pill Shows Promise After Stopping Fat Jabs May 18, 2026 New Oral Treatment Offers Hope for Weight Maintenance A daily tablet designed to help people maintain weight loss after stopping obesity injections has shown promising results. The medication, called orforglipron,…
Health Daily Pill Could Help Millions Keep Weight Off After Stopping Obesity Injections May 13, 2026 New Daily Pill Offers Hope for Long-Term Weight Management After Injection Therapy A new daily pill could help people maintain their weight loss after stopping obesity injections. The drug, called…